N. Blanpain and G. Buisson, Projections de population à l'horizon 2070 -Insee Première -1619, 2496228.

J. Robine, Estimation de l'espérance de vie sans incapacité en France en 2015 et évolution depuis 2004 : impact de la diminution de l'espérance de vie en 2015, Bull Epidemiol Hebd, issue.16?17, pp.294-300, 2017.

V. Bellamy and C. Beaumel, Bilan démographique 2015 Le nombre de décès au plus haut depuis l'après-guerre, Insee Prem, issue.1581, pp.1-4, 2016.

J. Robine and E. Cambois, Les espérances de vie en bonne santé des Européens Disponible sur: https, Popul Société [Internet], issue.499, 2013.

L. Fried, C. Tangen, J. Walston, A. Newman, C. Hirsch et al., Frailty in Older Adults: Evidence for a Phenotype, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.56, issue.3, pp.146-156, 2001.
DOI : 10.1093/gerona/56.3.M146

K. Rockwood, R. Fox, P. Stolee, D. Robertson, and B. Beattie, Frailty in elderly people: an evolving concept, CMAJ Can Med Assoc J J Assoc Medicale Can. 15 févr, vol.150, issue.4, pp.489-95, 1994.

T. Brennan, L. Leape, N. Laird, L. Hebert, A. Localio et al., Incidence of Adverse Events and Negligence in Hospitalized Patients, New England Journal of Medicine, vol.324, issue.6, pp.145-151, 2004.
DOI : 10.1056/NEJM199102073240604

B. Bégaud, K. Martin, A. Fourrier, and F. Haramburu, Does age increase the risk of adverse drug reactions?, Br J Clin Pharmacol. nov, vol.54, issue.5, pp.550-552, 2002.

Z. Marcum, M. Amuan, J. Hanlon, S. Aspinall, S. Handler et al., Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions in Older Veterans, Journal of the American Geriatrics Society, vol.57, issue.1, pp.34-41, 2012.
DOI : 10.1111/j.1532-5415.2009.02352.x

D. Qato, G. Alexander, R. Conti, M. Johnson, P. Schumm et al., Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States, JAMA. 24 déc, vol.300, issue.24, pp.2867-78, 2008.

A. Nobili, G. Licata, F. Salerno, L. Pasina, M. Tettamanti et al., Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study, European Journal of Clinical Pharmacology, vol.135, issue.5, pp.507-526, 2011.
DOI : 10.1038/clpt.2008.211

URL : https://hal.archives-ouvertes.fr/hal-00658700

S. Bronskill, S. Gill, J. Paterson, C. Bell, G. Anderson et al., Exploring Variation in Rates of Polypharmacy Across Long Term Care Homes, Journal of the American Medical Directors Association, vol.13, issue.3, pp.309-324, 2012.
DOI : 10.1016/j.jamda.2011.07.001

F. Bourgeois, M. Shannon, C. Valim, and K. Mandl, Adverse drug events in the outpatient setting: an 11-year national analysis, Pharmacoepidemiology and Drug Safety, vol.109, issue.2, pp.901-911, 2010.
DOI : 10.1016/S1553-7250(05)31050-6

C. Hohl, J. Dankoff, A. Colacone, and M. Afilalo, Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department, Annals of Emergency Medicine, vol.38, issue.6, pp.666-71, 2001.
DOI : 10.1067/mem.2001.119456

C. Mannesse, F. Derkx, and M. De-ridder, Contribution of adverse drug reactions to hospital admission of older patients, Age and Ageing, vol.29, issue.1, pp.35-44, 2000.
DOI : 10.1093/ageing/29.1.35

A. Conforti, D. Costantini, F. Zanetti, U. Moretti, M. Grezzana et al., Adverse drug reactions in older patients: an Italian observational prospective hospital study, Drug, Healthcare and Patient Safety, vol.4, pp.75-80, 2012.
DOI : 10.2147/DHPS.S29287

M. Franceschi, C. Scarcelli, V. Niro, D. Seripa, A. Pazienza et al., Prevalence, Clinical Features and Avoidability of Adverse Drug Reactions as Cause of Admission to??a??Geriatric Unit, Drug Safety, vol.12, issue.6, pp.545-56, 2008.
DOI : 10.1136/bmj.310.6983.827

C. Wu, C. Bell, and W. Wodchis, Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments, Drug Safety, vol.33, issue.11, pp.769-81, 2012.
DOI : 10.1345/aph.19036

. La-pharmacie-clinique, Disponible sur: http://gestions-hospitalieres.fr/la-pharmacie-clinique-source- dinformation-medicale, Gest Hosp [Internet]. 1 nov 2012, 2017.

G. Bouvenot, La prescription des médicaments chez la personne âgée | Académie nationale de médecine, Bull Académie Natl Médecine, vol.196, issue.4?5, pp.1031-1036, 2012.

T. Marquet, Le bon usage du m??dicament chez le sujet ??g?? de 80 ans et plus, Th??rapie, vol.60, issue.4, pp.367-71, 2005.
DOI : 10.2515/therapie:2005053

T. Gandhi, S. Weingart, J. Borus, A. Seger, J. Peterson et al., Adverse Drug Events in Ambulatory Care, New England Journal of Medicine, vol.348, issue.16, pp.1556-64, 2003.
DOI : 10.1056/NEJMsa020703

J. Gurwitz, T. Field, L. Harrold, J. Rothschild, K. Debellis et al., Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting, JAMA, vol.289, issue.9, pp.1107-1123, 2003.
DOI : 10.1001/jama.289.9.1107

E. Davies, C. Green, S. Taylor, P. Williamson, D. Mottram et al., Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes, PLoS ONE, vol.359, issue.15, p.4439, 2009.
DOI : 10.1371/journal.pone.0004439.t007

D. Budnitz, M. Lovegrove, N. Shehab, and C. Richards, Emergency hospitalizations for adverse drug events in older Americans, N Engl J Med. 24 nov, vol.365, issue.21, 2011.
DOI : 10.1056/nejmsa1103053

G. Bergen, M. Stevens, and E. Burns, Falls and Fall Injuries Among Adults Aged ?65 Years -United States, 2014. MMWR Morb Mortal Wkly Rep, pp.993-1001, 2016.
DOI : 10.15585/mmwr.mm6537a2

URL : https://www.cdc.gov/mmwr/volumes/65/wr/pdfs/mm6537a2.pdf

P. Thapa, K. Brockman, G. P. Fought, R. Ray, and W. , Injurious Falls in Nonambulatory Nursing Home Residents: A Comparative Study of Circumstances, Incidence, and Risk Factors, Journal of the American Geriatrics Society, vol.341, issue.suppl 4, pp.273-281, 1996.
DOI : 10.1016/0140-6736(93)92480-H

M. Tinetti, W. Liu, and S. Ginter, Mechanical Restraint Use and Fall-related Injuries among Residents of Skilled Nursing Facilities, Annals of Internal Medicine, vol.116, issue.5, pp.369-74, 1992.
DOI : 10.7326/0003-4819-116-5-369

M. Nevitt, S. Cummings, and E. Hudes, Risk Factors for Injurious Falls: a Prospective Study, Journal of Gerontology, vol.46, issue.5, pp.164-170, 1991.
DOI : 10.1093/geronj/46.5.M164

M. Tinetti, Preventing Falls in Elderly Persons, New England Journal of Medicine, vol.348, issue.1, pp.42-51, 2003.
DOI : 10.1056/NEJMcp020719

M. Tinetti, M. Speechley, and S. Ginter, Risk Factors for Falls among Elderly Persons Living in the Community, New England Journal of Medicine, vol.319, issue.26, pp.1701-1708, 1988.
DOI : 10.1056/NEJM198812293192604

B. Penninx, S. Pluijm, P. Lips, R. Woodman, K. Miedema et al., Late-Life Anemia Is Associated with Increased Risk of Recurrent Falls, Journal of the American Geriatrics Society, vol.43, issue.(S, pp.2106-2117, 2005.
DOI : 10.1111/j.1532-5415.1997.tb01480.x

D. Ganz, Y. Bao, P. Shekelle, and L. Rubenstein, Will my patient fall? JAMA. 3 janv, pp.77-86, 2007.
DOI : 10.1001/jama.297.1.77

J. Damián, R. Pastor-barriuso, E. Valderrama-gama, and J. De-pedro-cuesta, Factors associated with falls among older adults living in institutions, BMC Geriatrics, vol.158, issue.1, p.6, 2013.
DOI : 10.1093/aje/kwg203

S. Buatois, C. Perret-guillaume, R. Gueguen, P. Miget, G. Vançon et al., A Simple Clinical Scale to Stratify Risk of Recurrent Falls in Community-Dwelling Adults Aged 65 Years and Older, Physical Therapy, vol.90, issue.4, pp.550-60, 2010.
DOI : 10.2522/ptj.20090158

K. Freeland, A. Thompson, Y. Zhao, J. Leal, P. Mauldin et al., Medication Use and Associated Risk of Falling in a Geriatric Outpatient Population, Annals of Pharmacotherapy, vol.46, issue.9, pp.1188-92, 2012.
DOI : 10.1111/j.1532-5415.2005.00509.x

K. Ensrud, T. Blackwell, C. Mangione, P. Bowman, M. Whooley et al., Central Nervous System??????Active Medications and Risk for Falls in Older Women, Journal of the American Geriatrics Society, vol.36, issue.3, pp.1629-1666, 2002.
DOI : 10.1111/j.1532-5415.1988.tb06155.x

W. Ray, M. Griffin, and E. Malcolm, Cyclic Antidepressants and the Risk of Hip Fracture, Archives of Internal Medicine, vol.151, issue.4, pp.754-760, 1991.
DOI : 10.1001/archinte.1991.00400040096021

D. Lawlor, R. Patel, and S. Ebrahim, Association between falls in elderly women and chronic diseases and drug use: cross sectional study, BMJ, vol.327, issue.7417, pp.712-719, 2003.
DOI : 10.1136/bmj.327.7417.712

URL : http://www.bmj.com/content/bmj/327/7417/712.full.pdf

J. Woolcott, K. Richardson, M. Wiens, B. Patel, J. Marin et al., Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons, Archives of Internal Medicine, vol.169, issue.21, pp.1952-60, 2009.
DOI : 10.1001/archinternmed.2009.357

A. Tromp, S. Pluijm, J. Smit, D. Deeg, L. Bouter et al., Fall-risk screening test, Journal of Clinical Epidemiology, vol.54, issue.8, pp.837-881, 2001.
DOI : 10.1016/S0895-4356(01)00349-3

W. Ray, M. Griffin, W. Schaffner, D. Baugh, and L. Melton, Psychotropic Drug Use and the Risk of Hip Fracture, New England Journal of Medicine, vol.316, issue.7, pp.363-372, 1987.
DOI : 10.1056/NEJM198702123160702

B. Merz, Benzodiazepine use may raise risk of Alzheimer's disease [Internet] Harvard Health Blog Disponible sur: https, 2014.

M. Kotlarczyk, S. Perera, M. Ferchak, D. Nace, N. Resnick et al., Vitamin D deficiency is associated with functional decline and falls in frail elderly women despite supplementation, Osteoporosis International, vol.9, issue.7, pp.1347-53, 2017.
DOI : 10.1002/14651858.CD007146.pub3

A. Bond, F. Molnar, M. Li, M. Mackey, and M. Man-son-hing, The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy, Thromb J. 7 janv, vol.3, issue.1, p.1, 2005.

M. Andro, Chutes et anticoagulation, Réal Cardiol, issue.295, pp.21-25, 2013.

C. Garwood and T. Corbett, Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls, Annals of Pharmacotherapy, vol.165, issue.4, pp.523-555, 2008.
DOI : 10.2146/ajhp070301

M. Fang, C. J. Rich, and M. , Atrial Fibrillation in the Elderly, The American Journal of Medicine, vol.120, issue.6, pp.481-488, 2007.
DOI : 10.1016/j.amjmed.2007.01.026

H. Lin, P. Wolf, M. Kelly-hayes, A. Beiser, C. Kase et al., Stroke Severity in Atrial Fibrillation: The Framingham Study, Stroke, vol.27, issue.10, pp.1760-1764, 1996.
DOI : 10.1161/01.STR.27.10.1760

D. Poli, E. Antonucci, S. Testa, A. Tosetto, W. Ageno et al., Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment: Results of a Prospective Collaborative Study on Elderly Patients Followed by Italian Centres for Anticoagulation, Circulation, vol.124, issue.7, pp.824-833, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.007864

M. Man-son-hing, G. Nichol, A. Lau, and A. Laupacis, Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls, Archives of Internal Medicine, vol.159, issue.7, pp.677-85, 1999.
DOI : 10.1001/archinte.159.7.677

URL : http://archinte.jamanetwork.com/data/journals/intemed/11941/ioi80382.pdf

A. Khelifa, Syndromes démentiels Disponible sur: http://geriatrie.webs.com, 2009.

A. Nieoullon, Les anticholinestérasiques dans la maladie d'Alzheimer : réflexions sur leurs modalités d'action potentielles et les effets thérapeutiques, Psychol Neuropsychiatr Vieil, vol.8, issue.2, pp.123-154, 2010.

L. Médicaments-de-la-maladie, Alzheimer à visée symptomatique en pratique quotidienne Disponible sur: https, 2009.

J. Birks, G. Evans, and J. , Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev, p.1191, 2015.

M. Rösler, R. Anand, A. Cicin-sain, S. Gauthier, Y. Agid et al., Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial ?? Commentary: Another piece of the Alzheimer's jigsaw, BMJ, vol.318, issue.7184, pp.633-641, 1999.
DOI : 10.1136/bmj.318.7184.633

B. Winblad, J. Cummings, N. Andreasen, G. Grossberg, M. Onofrj et al., A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease?????? rivastigmine patchversus capsule, International Journal of Geriatric Psychiatry, vol.41, issue.5, pp.456-67, 2007.
DOI : 10.1111/j.1532-5415.1993.tb07308.x

L. Médicaments-de-la-maladie-d-'alzheimer, Prescrire [Internet], Disponible sur, 2008.

O. Hanon, Tolérance cardiovasculaire des anticholinestérasiques, Geriatr Psychol Neuropsychiatr Vieil, issue.10, pp.15-23, 2012.

|. Astex and . Azd3293, Beta Secretase (BACE) inhibitor (Alzheimer's disease) [Internet]. [cité 2 oct 2017]. Disponible sur: https://astx.com/research-development/partnered-products- and-programs/azd3293-lanabecestat-beta-secretase-bace-inhibitor-alzheimers-disease

J. Francis and Y. B. , Diagnosis of delirium and confusional states. UpToDate [Internet]. 2014; Disponible sur: https://www.uptodate.com/contents/diagnosis-of-delirium-and-confusional- states

J. Dimsdale, R. Newton, and T. Joist, Neuropsychological side effects of beta-blockers, Archives of Internal Medicine, vol.149, issue.3, pp.514-539, 1989.
DOI : 10.1001/archinte.149.3.514

A. Fisher, M. Davis, and I. Jeffery, Acute delirium induced by metoprolol, Cardiovascular Drugs and Therapy, vol.16, issue.2, pp.161-166, 2002.
DOI : 10.1023/A:1015761618314

J. Goldner, Metoprolol-induced visual hallucinations: a case series, Journal of Medical Case Reports, vol.223, issue.Suppl 3, p.65, 2012.
DOI : 10.1111/j.0954-6820.1988.tb17690.x

URL : https://doi.org/10.1186/1752-1947-6-65

M. Shear and M. Sacks, Digitalis Delirium: Psychiatric Considerations, The International Journal of Psychiatry in Medicine, vol.289, issue.4, pp.371-81, 19781977.
DOI : 10.1056/NEJM197311222892106

R. Howard, Digoxin toxicity caused by a decline in renal function. Prescriber, pp.41-44, 2007.

J. Clayton, L. Jeune, I. Hall, and I. , Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome, QJM, vol.99, issue.8, pp.505-516, 2006.
DOI : 10.1093/qjmed/hcl071

D. Shapiro, M. Sonnenblick, I. Galperin, L. Melkonyan, and G. Munter, ORIGINAL ARTICLE: Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome, Internal Medicine Journal, vol.84, issue.8, pp.574-80, 2010.
DOI : 10.1210/jcem.84.5.5631

K. Cumming, G. Hoyle, J. Hutchison, and R. Soiza, Prevalence, Incidence and Etiology of Hyponatremia in Elderly Patients with Fragility Fractures, PLoS ONE, vol.120, issue.2, p.88272, 2014.
DOI : 10.1371/journal.pone.0088272.t004

J. Rosholm, H. Nybo, A. Ranberg, K. Himmelstrup, B. Skjelbo et al., Hyponatraemia in Very Old Nonhospitalised People, Drugs & Aging, vol.41, issue.1, pp.685-93, 2002.
DOI : 10.2165/00002512-200219090-00005

S. Mann, The Silent Epidemic of Thiazide-Induced Hyponatremia, The Journal of Clinical Hypertension, vol.119, issue.1, pp.477-84, 2008.
DOI : 10.1016/j.amjmed.2005.09.026

K. Movig, H. Leufkens, A. Lenderink, V. Van-den-akker, P. Hodiamont et al., Association between antidepressant drug use and hyponatraemia: a case-control study, British Journal of Clinical Pharmacology, vol.8, issue.4, pp.363-372, 2002.
DOI : 10.1385/ENDO:8:1:13

K. Mangerel, Le pharmacien clinicien face aux syndromes gériatriques, J Pharmacol Clin, vol.33, issue.1, pp.7-19, 2014.

P. Joubaud, Variations en fonction de l'âge et du sexe de la clairance de la créatinine estimée selon Cockcroft et Gault dans une population sélectionnée d'adultes non hospitalisés, Ann Biol Clin, vol.62, issue.5, pp.547-54, 2004.

J. Faucher-grassin and J. Chapelle, Adapter la prescription et l'administration des médicaments à la personne âgée

C. Mclachlan, M. Yi, A. Ling, and D. Jardine, Adverse drug events are a major cause of acute medical admission, Internal Medicine Journal, vol.40, issue.7, pp.633-641, 2014.
DOI : 10.1111/j.1445-5994.2009.02040.x

P. Lang, Y. Hasso, J. Belmin, I. Payot, J. Baeyens et al., Adaptation en langue française d'un outil de détection de la prescription médicamenteuse inappropriée chez la personne âgée, Can J Public Health, vol.100, issue.6, pp.426-457, 2009.

J. Jyrkkä, H. Enlund, P. Lavikainen, R. Sulkava, and S. Hartikainen, Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population, Pharmacoepidemiology and Drug Safety, vol.57, issue.5, pp.514-536, 2011.
DOI : 10.1093/ageing/afm036

R. Heuberger and K. Caudell, Polypharmacy and Nutritional Status in Older Adults, Drugs & Aging, vol.82, issue.2, pp.315-338, 2011.
DOI : 10.1177/154405910308200209

T. In, Endocrinologie, diabète, métabolisme et nutrition, p.9782294715846

V. Kancherla, J. Elliott, B. Patel, N. Holland, T. Johnson et al., Long-term Metformin Therapy and Monitoring for Vitamin B12 Deficiency Among Older Veterans, Journal of the American Geriatrics Society, vol.67, issue.5, pp.1061-1067, 2017.
DOI : 10.1212/WNL.56.9.1143

M. Ahmed, G. Muntingh, and P. Rheeder, Vitamin B12 deficiency in metformin-treated type-2 diabetes patients, prevalence and association with peripheral neuropathy, BMC Pharmacology and Toxicology, vol.94, issue.1, p.44, 2016.
DOI : 10.3945/ajcn.111.013243

V. Aroda, S. Edelstein, R. Goldberg, W. Knowler, S. Marcovina et al., Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.4, pp.1754-61, 2016.
DOI : 10.1210/jc.2015-3754

S. Ko, S. Ko, Y. Ahn, K. Song, K. Han et al., Deficiency and Metformin Use in Patients with Type 2 Diabetes, Journal of Korean Medical Science, vol.29, issue.7, pp.965-72, 2014.
DOI : 10.3346/jkms.2014.29.7.965

L. Pennypacker, R. Allen, J. Kelly, L. Matthews, J. Grigsby et al., High Prevalence of Cobalamin Deficiency in Elderly Outpatients, Journal of the American Geriatrics Society, vol.40, issue.12, pp.1197-204, 1992.
DOI : 10.1111/j.1532-5415.1992.tb01939.x

P. Wiffen, S. Derry, and M. R. L-'impact-de-la-morphine, du fentanyl, de l'oxycodone ou de la codéine sur la conscience, l'appétit et la soif du patient lorsqu'ils sont utilisés pour traiter la douleur du cancer | Cochrane

W. Taylor, Depression in the Elderly, New England Journal of Medicine, vol.371, issue.13, pp.1228-1264, 2014.
DOI : 10.1056/NEJMcp1402180

J. Aubry, P. Berney, M. Besson, and L. Curtis, Guide pour l'emploi des psychotropes d'usage courant

K. Segers and M. Surquin, Can Mirtazapine Counteract the Weight Loss Associated With Alzheimer Disease? A Retrospective Open-label Study, Alzheimer Disease & Associated Disorders, vol.28, issue.3, pp.291-294, 2014.
DOI : 10.1097/WAD.0b013e3182614f52

P. Le, Ministère des Solidarités et de la Santé Disponible sur: http://solidarites-sante.gouv.fr/systeme-de-sante-et-medico-social/parcours-des- patients, 2017.

N. Salles, Enquête nationale sur les pratiques des Equipes Mobiles de Gériatrie en France. Groupe de travail des équipes mobiles de gériatrie de la SFGG, Rev Gériatrie, vol.37, issue.9, pp.738-779, 2012.

V. Garnier, G. Corte-franco, and P. Couturier, Contribution à l'amélioration des pratiques en EMG : les recommandations et leur suivi, Rev Gériatrie, vol.37, issue.9, p.764, 2012.

T. Morin, I. Lanièce, A. Desbois, S. Amiard, G. Gavazzi et al., Evaluation du suivi des recommandations à 3 mois après prise en charge par une équipe mobile gériatrique hospitalière, Geriatr Psychol Neuropsychiatr Vieil, vol.10, issue.3, pp.285-93, 2012.

B. Laquet, A. Gromier, and P. Couturier, Amélioration des pratiques de soins aux urgences par les EMG, Rev Gériatrie, vol.37, issue.9, pp.765-771, 2012.

G. Ellis, M. Whitehead, O. Neill, D. Langhorne, P. Robinson et al., Comprehensive geriatric assessment for older adults admitted to hospital, Cochrane Database Syst Rev. 6 juill, issue.7, p.6211, 2011.
DOI : 10.1002/14651858.cd006211

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164377/pdf

G. Définition-de-la-pharmacie-clinique-hospitalière-selon-la, Association suisse des pharmaciens de l'administration et des hôpitaux)

M. Claire, Les indicateurs SFPC Pharmacie hospitalière 2015

B. Farrell, K. Pottie, W. Thompson, T. Boghossian, L. Pizzola et al., Déprescrire les inhibiteurs de la pompe à protons. Lignes directrices de pratique clinique fondées sur les données probantes, Can Fam Physician, issue.63, pp.354-64, 2017.

V. Leflon-guibout, G. Ternat, B. Heym, and M. Nicolas-chanoine, Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection, Journal of Antimicrobial Chemotherapy, vol.49, issue.2, pp.367-71, 2002.
DOI : 10.1093/jac/49.2.367

L. Commission-de and . Transparence, Disponible sur: https://www.has-sante.fr/portail/upload/docs/application, Piracétam : risque hémorragique. Rev Prescrire, vol.25, issue.257, p.23, 2005.

M. Steinman and J. Hanlon, Managing Medications in Clinically Complex Elders, JAMA, vol.304, issue.14, pp.1592-601, 2010.
DOI : 10.1001/jama.2010.1482

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981606/pdf

M. Beers, J. Ouslander, I. Rollingher, D. Reuben, J. Brooks et al., Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine, Archives of Internal Medicine, vol.151, issue.9, pp.1825-1857, 1991.
DOI : 10.1001/archinte.151.9.1825

M. Beers, Explicit criteria for determining potentially inappropriate medication use by the elderly. An update, Archives of Internal Medicine, vol.157, issue.14, pp.1531-1537, 1997.
DOI : 10.1001/archinte.157.14.1531

C. Campanelli, American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, J Am Geriatr Soc. avr, vol.60, issue.4, pp.616-647, 2012.

M. Laroche, Le risque iatrogène chez la personne âgée : à propos des médicaments potentiellement inappropriés [Internet]. Limoges, Disponible sur, 2007.